Cargando…
Cell-free circulating tumor DNA analysis for breast cancer and its clinical utilization as a biomarker
Circulating tumor DNA (ctDNA) in the blood of cancer patients contains much information on genetic and epigenetic profiles associated with cancer development, progression, and response to therapy. Analysis of ctDNA provides an opportunity for non-invasive sampling of tumor DNA repetitiously and ther...
Autores principales: | Wang, Ru, Li, Xiao, Zhang, Huimin, Wang, Ke, He, Jianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650461/ https://www.ncbi.nlm.nih.gov/pubmed/29088906 http://dx.doi.org/10.18632/oncotarget.20608 |
Ejemplares similares
-
Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors
por: Kohler, Corina, et al.
Publicado: (2009) -
Utility of Circulating Tumor DNA in Different Clinical Scenarios of Breast Cancer
por: Mesquita, Alexandra, et al.
Publicado: (2020) -
Circulating Tumor DNA as Biomarkers for Cancer Detection
por: Han, Xiao, et al.
Publicado: (2017) -
Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
por: Chen, Qian, et al.
Publicado: (2019) -
Clinical utility of circulating tumor DNA for colorectal cancer
por: Osumi, Hiroki, et al.
Publicado: (2019)